Blood test guides aggressive attack on spreading stomach and pancreatic cancers
NCT ID NCT07282912
Summary
This study is for people with advanced cancer that started in the upper digestive tract (like the stomach, pancreas, or bile ducts) and has spread to only a few other places. After three months of chemotherapy, if a special blood test finds no cancer DNA, patients are randomly assigned to either continue standard chemotherapy alone or to also receive targeted treatments like surgery or radiation to remove the remaining tumors. The main goal is to see if adding these local treatments helps keep the cancer from growing back longer than chemotherapy alone.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ESOPHAGEAL ADENOCARCINOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Smilow Cancer Center
RECRUITINGNew Haven, Connecticut, 06519, United States
Conditions
Explore the condition pages connected to this study.